Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × NIH × Healthy Subject × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 120 Unspecified Adult Solid Tumor, Protocol Specific 113 Leukemia, Lymphocytic, Chronic, B-Cell 105 Lymphoma 89 Breast Neoplasms 88 Neoplasms 87 Lymphoma, Large B-Cell, Diffuse 86 Burkitt Lymphoma 86 Lymphoma, Follicular 85 Lymphoma, Non-Hodgkin 83 Leukemia, Myeloid, Acute 80 Lymphoma, Mantle-Cell 77 Neoplasm Metastasis 70 Lymphoma, B-Cell, Marginal Zone 69 Lymphoma, Large-Cell, Immunoblastic 64 Carcinoma, Non-Small-Cell Lung 62 Melanoma 55 Lymphoma, T-Cell, Cutaneous 55 Lung Neoplasms 55 Hodgkin Disease 55 Lymphoma, Large-Cell, Anaplastic 53 Colonic Neoplasms 53 Brain Neoplasms 53 Astrocytoma 52 Prostatic Neoplasms 51 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 50 Mycosis Fungoides 50 Sezary Syndrome 48 Glioblastoma 47 Leukemia 46

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01935960 2016-12-23

Retinoid 9cUAB30 in Preventing Cancer in Healthy Volunteers

National Cancer Institute (NCI)

Phase 1 Completed

Healthy Subject

Data powered by HemOnc (CC BY 4.0) Colophon ⚡